Chemoinformaics analysis of Butyl methyl trisulfide
| Molecular Weight | 168.352 | nRot | 5 |
| Heavy Atom Molecular Weight | 156.256 | nRig | 0 |
| Exact Molecular Weight | 168.01 | nRing | 0 |
| Solubility: LogS | -4.758 | nHRing | 0 |
| Solubility: LogP | 2.642 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 20 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 8 | No. of Aromatic Carbocycles | 0 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 5 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 3 | APOL | 25.0515 |
| nHD | 0 | BPOL | 14.4985 |
| QED | 0.456 |
| Synth | 3.284 |
| Natural Product Likeliness | 1.199 |
| NR-PPAR-gamma | 0.006 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.008 |
| HIA | 0.005 |
| CACO-2 | -4.428 |
| MDCK | 0.0000278 |
| BBB | 0.711 |
| PPB | 0.569573 |
| VDSS | 1.172 |
| FU | 0.239016 |
| CYP1A2-inh | 0.954 |
| CYP1A2-sub | 0.932 |
| CYP2c19-inh | 0.968 |
| CYP2c19-sub | 0.882 |
| CYP2c9-inh | 0.806 |
| CYP2c9-sub | 0.813 |
| CYP2d6-inh | 0.073 |
| CYP2d6-sub | 0.725 |
| CYP3a4-inh | 0.026 |
| CYP3a4-sub | 0.241 |
| CL | 11.759 |
| T12 | 0.191 |
| hERG | 0.216 |
| Ames | 0.534 |
| ROA | 0.855 |
| SkinSen | 0.949 |
| Carcinogencity | 0.302 |
| EI | 0.995 |
| Respiratory | 0.982 |
| NR-Aromatase | 0.033 |
| Antiviral | No |
| Prediction | 0.956914 |